Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protective Effects of Statins Administration in European and North American Patients Infected with COVID-19: A Meta-Analysis
Mairi Pucci, Diletta Onorato, Giovanni Carpenè, et al.
Seminars in Thrombosis and Hemostasis (2021) Vol. 47, Iss. 04, pp. 392-399
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies
Suowen Xu, Iqra Ilyas, Jianping Weng
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 4, pp. 695-709
Open Access | Times Cited: 273
Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19
Aakriti Gupta, Mahesh V. Madhavan, Timothy J. Poterucha, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 176
Understanding the molecular mechanisms of statin pleiotropic effects
Charles German, James K. Liao
Archives of Toxicology (2023) Vol. 97, Iss. 6, pp. 1529-1545
Open Access | Times Cited: 55
Cholesterol and Triglyceride Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression
Angelo Zinellu, Panagiotis Paliogiannis, Alessandro G. Fois, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 67
Statins—From Fungi to Pharmacy
Anna Sadowska, Patryk Osiński, Alicja Roztocka, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 466-466
Open Access | Times Cited: 21
Neurovascular coupling impairment as a mechanism for cognitive deficits in COVID-19
Cameron D. Owens, Camila Bonin Pinto, Sam Detwiler, et al.
Brain Communications (2024) Vol. 6, Iss. 2
Open Access | Times Cited: 10
The use of statins was associated with reduced COVID-19 mortality: a systematic review and meta-analysis
Kuan‐Sheng Wu, Pei‐Chin Lin, Yao-Shen Chen, et al.
Annals of Medicine (2021) Vol. 53, Iss. 1, pp. 874-884
Open Access | Times Cited: 42
Protective effects of statins on COVID-19 risk, severity and fatal outcome: a nationwide Swedish cohort study
Ailiana Santosa, Stefan Franzén, Jonatan Nåtman, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 33
Statin and aspirin as adjuvant therapy in hospitalised patients with SARS-CoV-2 infection: a randomised clinical trial (RESIST trial)
Nirmal Ghati, Sushma Bhatnagar, Manjit Mahendran, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 32
Lipid-targeting antiviral strategies: current state and future perspectives
Ana-Belén Blázquez, Patricia Mingo‐Casas, Ernesto Quesada, et al.
Antiviral Research (2025), pp. 106103-106103
Closed Access
Atorvastatin Attenuated the Inflammatory Outcomes of COVID-19: A Double-Blind, Randomized Controlled Trial
Hajar Shokri‐Afra, Sudabe Baghery moghadam, Ziaeddin Oladi, et al.
Journal of Reports in Pharmaceutical Sciences (2025) Vol. 13, Iss. 1
Open Access
COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection
Stanisław Surma, Maciej Banach, Joanna Lewek
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 38
Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative Review
Carles Vilaplana-Carnerero, Maria Giner‐Soriano, Ángela Domı́nguez, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1206-1206
Open Access | Times Cited: 14
Systematic Review and Meta-Analysis of Statin Use and Mortality, Intensive Care Unit Admission and Requirement for Mechanical Ventilation in COVID-19 Patients
Ut-Sam Lao, Chak-Fun Law, Daniel T. Baptista‐Hon, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 18, pp. 5454-5454
Open Access | Times Cited: 19
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II
Emmanuel J. Favaloro, Giuseppe Lippi
Seminars in Thrombosis and Hemostasis (2021) Vol. 47, Iss. 04, pp. 333-337
Closed Access | Times Cited: 25
Statin Use Is Associated with a Decreased Risk of Mortality among Patients with COVID-19
Chieh-Chen Wu, An-Jen Lee, Chun-Hsien Su, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 7, pp. 1450-1450
Open Access | Times Cited: 20
2023 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles
Emmanuel J. Favaloro
Seminars in Thrombosis and Hemostasis (2023) Vol. 49, Iss. 05, pp. 417-426
Open Access | Times Cited: 8
The Value of Clinical Frailty Scale (CFS) as a Prognostic Tool in Predicting Mortality in COVID-19—A Retrospective Cohort Study
Magdalena Jachymek, Aleksandra Cader, Michał Ptak, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 3, pp. 1104-1104
Open Access | Times Cited: 12
Coronaviruses, cholesterol and statins: Involvement and application for Covid-19
Stéphane Orlowski, Jean‐Jacques Mourad, Antonio Gallo, et al.
Biochimie (2021) Vol. 189, pp. 51-64
Open Access | Times Cited: 15
Association of statin use with outcomes of patients admitted with COVID-19: an analysis of electronic health records using superlearner
Adovich S. Rivera, Omar Al-Heeti, Lucia C. Petito, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
New Seminars in Thrombosis and Hemostasis 2022 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics
Emmanuel J. Favaloro
Seminars in Thrombosis and Hemostasis (2023) Vol. 49, Iss. 07, pp. 661-669
Open Access | Times Cited: 5
New STH 2023 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics
Emmanuel J. Favaloro
Seminars in Thrombosis and Hemostasis (2024) Vol. 50, Iss. 08, pp. 1058-1066
Closed Access | Times Cited: 1
Could Statin Therapy Be Useful in Patients With Coronavirus Disease 2019 (COVID-19)?
José D. Torres‐Peña, Niki Katsiki, Pablo Pérez‐Martínez
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 12
2022 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles
Emmanuel J. Favaloro
Seminars in Thrombosis and Hemostasis (2022) Vol. 48, Iss. 05, pp. 502-513
Open Access | Times Cited: 8
Outpatient atorvastatin use and severe COVID‐19 outcomes: A population‐based study
Irene Visos‐Varela, Maruxa Zapata‐Cachafeiro, Samuel Pintos‐Rodríguez, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 7
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top